The power of saliva: Antimicrobial and beyond

Autoři: Taissa Vila aff001;  Alexandra M. Rizk aff001;  Ahmed S. Sultan aff001;  Mary Ann Jabra-Rizk aff001
Působiště autorů: Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland, Baltimore, United States of America aff001;  Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, United States of America aff002
Vyšlo v časopise: The power of saliva: Antimicrobial and beyond. PLoS Pathog 15(11): e1008058. doi:10.1371/journal.ppat.1008058
Kategorie: Pearls
prolekare.web.journal.doi_sk: 10.1371/journal.ppat.1008058


1. Sultan AS, Kong EF, Jabra-Rizk MA. The oral microbiome: A lesson in co-existence. PLoS Pathog. 2018;14(1):e1006719. doi: 10.1371/journal.ppat.1006719 29370304

2. Amerongen A, Veerman E. Saliva: the defender of the oral cavity. Oral Dis. 2002;8(1):12–22. 11936451

3. Zhang CZ, Cheng XQ, Li JY, Zhang P, Yi P, Xu X, et al. Saliva in the diagnosis of diseases. Int J Oral Sci. 2016 8(3):133–7. doi: 10.1038/ijos.2016.38 27585820

4. Dawes C, Pedersen AM, Villa A, Ekström J, Proctor GB, Vissink A, et al. The functions of human saliva: A review sponsored by the World Workshop on Oral Medicine VI. Arch Oral Biol 2015;60(6):863–74. doi: 10.1016/j.archoralbio.2015.03.004 25841068

5. Salvatori O, Puri S, Tati S, Edgerton M. Innate immunity and saliva in Candida albicans-mediated oral diseases. J Dent Res. 2016;95(4):365–71. doi: 10.1177/0022034515625222 26747422

6. Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, et al. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med. 2017;6(12):2918–31. doi: 10.1002/cam4.1221 29071801

7. van 't Hof W, Veerman EC, Nieuw Amerongen AV, Ligtenberg AJ. Antimicrobial defense systems in saliva. Monogr Oral Sci 2014; 24:52–60. 2014;24:40–51. doi: 10.1159/000358784

8. Gorr S. Antimicrobial peptides of the oral cavity. Periodontol 2000. 2009;51:152–80. doi: 10.1111/j.1600-0757.2009.00310.x 19878474

9. Mochon AB, Liu H. The antimicrobial peptide histatin-5 causes a spatially restricted disruption on the Candida albicans surface allowing rapid entry of the peptide into the cytoplasm. PLoS Pathog. 2008;4(10):e1000190. doi: 10.1371/journal.ppat.1000190 18974864

10. Edgerton M, Koshlukova SE, Araujo MWB, Patel RC, Dong J, Bruenn J. Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Animicrobial Agents and Chemotherapy. 2000;44(12):3310–6.

11. Khurshid Z, Naseem M, Yahya F, Mali M, Sannam KR, Sahibzada HA, et al. Significance and diagnostic role of antimicrobial cathelicidins (LL-37) peptides in oral health. Biomolecules. 2017;7(4): doi: 10.3390/biom7040080 29206168

12. Abiko Y, Nishimura M, Kaku T. Defensins in saliva and the salivary glands. Med Electron Microscopy. 2003;36:247–52.

13. Meade KG, O'Farrelly C. β-Defensins: Farming the microbiome for homeostasis and health. Front Immunol. 2019 25(9):3072.

14. Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, et al. Histatins, a novel family of histidine-rich proteins in human parotid secretion. The Journal of Biological Chemistry. 1988;263(16):7472–7. 3286634

15. Edgerton M, Koshlukova S, Lo T, Chrzan B, Straubinger R, Raj P. Candidacidal activity of salivary histatins. J Biol Chem. 1998;272(32):20438–47.

16. Li XS, Reddy MS, Baev D, Edgerton M. Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5. The Journal of Biological Chemistry. 2003;278(31):28553–61. doi: 10.1074/jbc.M300680200 12761219

17. Gyurko C, Lendenmann U, Helmerhorst EJ, Troxler RF, Oppenheim FG. Killing of Candida albicans by histatin 5: cellular uptake and energy requirement. Antonie van Leeuwenhoek. 2001;79:297–309. doi: 10.1023/a:1012070600340 11816973

18. Leito JT, Ligtenberg AJ, Nazmi K, Veerman EC. Identification of salivary components that induce transition of hyphae to yeast in Candida albicans. FEMS Yeast Res. 2009;9(7):1102–10. doi: 10.1111/j.1567-1364.2009.00575.x 19799638

19. Jabra-Rizk MA, Kong E, Tsui C, Nguyen M, Clancy C, Fidel P, et al. Candida albicans pathogenesis: Fitting within the host-microbe damage response framework. Infect Immun. 2016;84(10):2724–39. doi: 10.1128/IAI.00469-16 27430274

20. Moffa EB, Mussi MCM, Xiao Y, Garrido SS, Machado MAAM, Giampaolo ET, et al. Histatin 5 inhibits adhesion of C. albicans to reconstructed human oral epithelium. Front Microbiol. 2015;6(885): doi: 10.3389/fmicb.2015.00885 26379655

21. Vivino F, Bunya VY, Massaro-Giordano G, Johr CR, Giattino SL, Schorpion A, et al. Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol. 2019 22: doi: 10.1016/j.clim.2019.04.009 31022578

22. Sweet SP, Denbury AN, Challacombe SJ. Salivary calprotectin levels are aised in patients with oral candidiasis or Sjögren’s syndrome but decreased by HIV infection. Oral Microbiol Immunol 2001;16(2):119–23. doi: 10.1034/j.1399-302x.2001.016002119.x 11240866

23. Lin AL, Johnson DA, Stephan KT, Yeh CK. Alteration in salivary function in early HIV infection. J Dent Res. 2003 8;2(9):719–24.

24. Khan SA, Fidel P Jr, Al Thunayyan A, Meiller T, Jabra-Rizk MA. Impaired histatin-5 level and salivary antimicrobial activity against C. albicans in HIV-infected individuals. J AIDS Clin Res. 2013;4(2):1–6.

25. Gaffen S H-SN, Peterson A. IL-17 Signaling in host defense against Candida albicans. Immunol Res. 2011;50:181–7. doi: 10.1007/s12026-011-8226-x 21717069

26. Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA. Mucins in the mucosal barrier to infection. Mucosal Immunol. 2008;1(3):183–97. doi: 10.1038/mi.2008.5 19079178

27. Brand H, Ligtenberg A, Veerman E. Saliva and wound healing. Monogr Oral Sci. 2014;24 52–60. doi: 10.1159/000358784 24862594

28. Torres P, Castro M, Reyes M, Torres VA. Histatins, wound healing and cell migration. Oral Dis. 2018;24:1150–60. doi: 10.1111/odi.12816 29230909

29. Oudhoff MJ, Bolscher JGM, Nazmi K, Kalay H, van 't Hof W, Nieuw Amerongen AV, et al. Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay. The FASEB Journal. 2008;22:3805–12. doi: 10.1096/fj.08-112003 18650243

30. Wisner A, Dufour E, Messaoudi M, Nejdi A, Marcel A, Ungeheuer MN, et al. Human opiorphin, a natural antinociceptive modulator of opioid-dependent pathways. Proc Natl Acad Sci U S A. 2006;103(47):17979–84. doi: 10.1073/pnas.0605865103 17101991

31. Shah S. Salivaomics: The current scenario. J Oral Maxillofac Pathol 2018 22(3):375–81. doi: 10.4103/jomfp.JOMFP_171_18 30651683

32. Wong D.T. Salivaomics. J Am Dent Assoc. 2012;143(10 Suppl):19S–24S.

33. Tasoulas J, Patsouris E, Giaginis C, Theocharis S. Salivaomics for oral diseases biomarkers detection. Expert Rev Molec Diag 2016 16(3):285–95

34. Ilea A, Andrei V, Feurdean CN, Băbțan AM, Petrescu NB, Câmpian RS, et al. Saliva, a magic biofluid available for multilevel assessment and a mirror of general health-A systematic review. Biosensors. 2019;9(1): doi: 10.3390/bios9010027 30769890

Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens

2019 Číslo 11

Najčítanejšie v tomto čísle

Tejto téme sa ďalej venujú…

Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.


Nemáte účet?  Registrujte sa